Certolizumab Ab:MCnc:Pt:Ser/Plas:Qn:SPR

Preferred Label : Certolizumab Ab:MCnc:Pt:Ser/Plas:Qn:SPR;

LOINC status : ACTIVE;

LOINC display name : Certolizumab Ab SPR [Mass/Vol];

LOINC long common name : Certolizumab Ab [Mass/volume] in Serum or Plasma by SPR;

LOINC short name : Certolizumab Ab SerPl SPR-mCnc;

Détails

Origin ID

101724-3;

UMLS CUI

C5831108;

Has component
- Certolizumab [LOINC component]
- Certolizumab Ab [LOINC component]
Has method
- SPR [LOINC method]
Has property
- Mass Concentration [LOINC Property]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients